Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation.
de Jong, Mark R
Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation. [electronic resource] - Clinical research in cardiology : official journal of the German Cardiac Society Jul 2018 - 539-547 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
1861-0692
10.1007/s00392-018-1214-6 doi
Atrial Fibrillation--diagnosis
Catheter Ablation--adverse effects
Clinical Protocols
Europe
Humans
Hypertension--complications
Prospective Studies
Pulmonary Veins--physiopathology
Recurrence
Renal Artery--innervation
Research Design
Risk Factors
Sympathectomy--adverse effects
Sympathetic Nervous System--physiopathology
Time Factors
Treatment Outcome
Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation. [electronic resource] - Clinical research in cardiology : official journal of the German Cardiac Society Jul 2018 - 539-547 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
1861-0692
10.1007/s00392-018-1214-6 doi
Atrial Fibrillation--diagnosis
Catheter Ablation--adverse effects
Clinical Protocols
Europe
Humans
Hypertension--complications
Prospective Studies
Pulmonary Veins--physiopathology
Recurrence
Renal Artery--innervation
Research Design
Risk Factors
Sympathectomy--adverse effects
Sympathetic Nervous System--physiopathology
Time Factors
Treatment Outcome